Camson Bio Technologies Ltd

Camson Bio Technologies Ltd

₹ 3.31 -1.78%
11 May 2020
About

Camson Bio Technologies is engaged in the Business of Agricultural Biotech Products.

  • Market Cap 9.93 Cr.
  • Current Price 3.31
  • High / Low /
  • Stock P/E
  • Book Value 22.2
  • Dividend Yield 0.00 %
  • ROCE -4.97 %
  • ROE -20.2 %
  • Face Value 10.0

Pros

  • Stock is trading at 0.15 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -32.7% over past five years.
  • Company has a low return on equity of -24.5% over last 3 years.
  • Contingent liabilities of Rs.20.4 Cr.
  • Earnings include an other income of Rs.1.30 Cr.
  • Working capital days have increased from 132 days to 445 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015
53.11 37.73 59.46 54.20 39.49 46.24 47.10 63.51 46.17
43.48 29.89 56.58 49.42 30.29 39.04 42.39 55.99 50.85
Operating Profit 9.63 7.84 2.88 4.78 9.20 7.20 4.71 7.52 -4.68
OPM % 18.13% 20.78% 4.84% 8.82% 23.30% 15.57% 10.00% 11.84% -10.14%
0.08 -3.43 0.31 0.05 0.04 0.02 0.15 0.35 5.90
Interest 0.67 0.90 0.85 0.90 1.22 1.15 0.84 1.02 2.08
Depreciation 0.58 1.23 1.26 1.28 1.35 3.34 3.36 3.51 3.79
Profit before tax 8.46 2.28 1.08 2.65 6.67 2.73 0.66 3.34 -4.65
Tax % -0.83% 4.39% 51.85% 8.30% -20.39% -45.05% 66.67% 56.89% 18.71%
8.53 2.17 0.52 2.43 8.03 3.96 0.22 1.45 -5.52
EPS in Rs 4.56 1.00 0.18 0.96 3.19 1.42 0.08 0.58 -1.35
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
95 134 186 191 61 14 18
73 104 161 176 76 29 18
Operating Profit 22 29 25 15 -15 -14 0
OPM % 23% 22% 13% 8% -24% -100% 0%
0 0 -3 6 1 4 1
Interest 0 2 4 5 7 7 5
Depreciation 2 3 5 14 23 8 7
Profit before tax 20 24 13 2 -44 -25 -11
Tax % -1% 2% -4% 95% -5% -1% 0%
21 24 13 0 -41 -30 -14
EPS in Rs 11.45 12.99 5.23 0.65 -13.15 -9.88 -4.77
Dividend Payout % 9% 8% 19% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: -33%
3 Years: -54%
TTM: 28%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 52%
Stock Price CAGR
10 Years: %
5 Years: -23%
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: -9%
3 Years: -24%
Last Year: -20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
Equity Capital 18 18 25 30 30 30 30
Reserves 107 129 179 233 72 45 37
12 41 40 47 61 46 49
15 45 47 39 32 24 26
Total Liabilities 153 233 291 349 195 145 142
35 78 110 153 119 95 88
CWIP 22 0 0 0 0 0 0
Investments 0 0 0 0 0 1 3
96 155 182 196 76 49 50
Total Assets 153 233 291 349 195 145 142

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
10 -13 -16 18 -19 5 5
-20 -25 -35 -54 12 3 -3
9 39 51 35 7 -7 -2
Net Cash Flow -1 1 0 -1 -0 -0 0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
Debtor Days 180 220 184 305 171 94 101
Inventory Days 543 270 133 96 113 575 1,917
Days Payable 102 122 36 67 156 360 392
Cash Conversion Cycle 621 367 281 334 128 309 1,626
Working Capital Days 293 271 226 307 77 -126 445
ROCE % 16% 9% 3% -15% -13% -5%

Shareholding Pattern

Numbers in percentages

Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46%
19.57% 19.81% 19.81% 19.81% 19.81% 19.81% 19.81% 19.81% 19.81% 19.57% 19.57% 19.57%
1.98% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
53.99% 55.73% 55.73% 55.73% 55.73% 55.73% 55.73% 55.73% 55.73% 55.97% 55.97% 55.97%
No. of Shareholders 11,36811,38410,99310,75210,0509,8719,7409,6289,6069,4839,3209,221

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents